Lv1
30 积分 2025-01-07 加入
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
24天前
已完结
以分子分型为基础的胃癌精准治疗策略及发展趋势
1个月前
已完结
Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2− advanced breast cancer: A multicenter retrospective study
2个月前
已关闭
Efficacy and safety of fruquintinib combined with PD-1 inhibitors in the treatment of refractory metastatic colorectal cancer: a systematic review and meta-analysis
2个月前
已完结
JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN)
8个月前
已完结
Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era
8个月前
已完结
Chronic Myeloid Leukemia
8个月前
已完结
Precision in Diagnostic Molecular Pathology based on Immunohistochemistry
8个月前
已完结
健康管理视角下多重慢病患者用药安全与药物管理策略
9个月前
已完结
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
9个月前
已完结
皖公网安备34019202002308
